AC Immune S.A.ACIUNASDAQ
Loading
R&D Expense Growth TrendStable
Percentile Rank64
3Y CAGR+45.9%
5Y CAGR+1.0%
Year-over-Year Change
Year-over-year research & development expense growth
3Y CAGR
+45.9%/yr
vs -35.2%/yr prior
5Y CAGR
+1.0%/yr
Recent acceleration
Acceleration
+81.1pp
Accelerating
Percentile
P64
Within normal range
vs 5Y Ago
1x
Modest growth
Streak
1 yr
Consecutive growthStable
| Period | Value |
|---|---|
| 2024 | 14.58% |
| 2023 | -9.50% |
| 2022 | -3.12% |
| 2021 | 4.70% |
| 2020 | 17.95% |
| 2019 | 13.90% |
| 2018 | 35.56% |
| 2017 | 26.73% |
| 2016 | 51.18% |
| 2015 | 5.79% |